Pfizer Inc (PFE)
26.27
-0.05
(-0.19%)
USD |
NYSE |
Apr 24, 16:00
26.24
-0.03
(-0.11%)
Pre-Market: 07:50
Pfizer Cash from Operations (TTM): 8.70B for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 8.70B |
September 30, 2023 | 12.04B |
June 30, 2023 | 14.56B |
March 31, 2023 | 23.94B |
December 31, 2022 | 29.27B |
September 30, 2022 | 26.60B |
June 30, 2022 | 31.45B |
March 31, 2022 | 34.58B |
December 31, 2021 | 32.58B |
September 30, 2021 | 32.29B |
June 30, 2021 | 23.55B |
March 31, 2021 | 15.81B |
December 31, 2020 | 14.40B |
September 30, 2020 | 12.55B |
June 30, 2020 | 14.97B |
March 31, 2020 | 14.02B |
December 31, 2019 | 12.59B |
September 30, 2019 | 13.56B |
June 30, 2019 | 14.31B |
March 31, 2019 | 15.54B |
December 31, 2018 | 15.83B |
September 30, 2018 | 18.18B |
June 30, 2018 | 17.81B |
March 31, 2018 | 17.20B |
December 31, 2017 | 16.80B |
Date | Value |
---|---|
September 30, 2017 | 15.75B |
June 30, 2017 | 15.60B |
March 31, 2017 | 15.97B |
December 31, 2016 | 16.19B |
September 30, 2016 | 15.05B |
June 30, 2016 | 15.33B |
March 31, 2016 | 15.82B |
December 31, 2015 | 14.69B |
September 30, 2015 | 15.39B |
June 30, 2015 | 14.83B |
March 31, 2015 | 14.83B |
December 31, 2014 | 17.08B |
September 30, 2014 | 17.21B |
June 30, 2014 | 18.65B |
March 31, 2014 | 18.32B |
December 31, 2013 | 17.68B |
September 30, 2013 | 16.91B |
June 30, 2013 | 16.01B |
March 31, 2013 | 16.28B |
December 31, 2012 | 16.75B |
September 30, 2012 | 17.06B |
June 30, 2012 | 16.50B |
March 31, 2012 | 18.37B |
December 31, 2011 | 20.24B |
September 30, 2011 | 21.24B |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
8.70B
Minimum
Dec 2023
34.58B
Maximum
Mar 2022
20.09B
Average
14.97B
Median
Jun 2020
Cash from Operations (TTM) Benchmarks
Amgen Inc | 8.471B |
Gilead Sciences Inc | 8.006B |
Johnson & Johnson | 22.79B |
Viking Therapeutics Inc | -73.38M |
Moderna Inc | -3.118B |